Related Experiment Videos
Org 4333, a potent, irreversibly binding estrogen agonist
Pharmaceutisch Weekblad. Scientific Edition
|August 26, 1983
Summary
Researchers developed two methods to synthesize 11 beta-chloromethylestra-1,3,5(10)-trien-3,17 beta-diol (Org 4333). This novel estrogen agonist demonstrated potent, irreversible binding in biological tests.
Area of Science:
- Organic Chemistry
- Endocrinology
- Pharmacology
Background:
- Estrogen agonists play a crucial role in various physiological processes.
- Development of novel estrogenic compounds with specific binding properties is an active area of research.
Purpose of the Study:
- To describe two novel synthetic routes for 11 beta-chloromethylestra-1,3,5(10)-trien-3,17 beta-diol (Org 4333).
- To evaluate the biological activity of Org 4333 as an estrogen agonist.
Main Methods:
- Chemical synthesis of 11 beta-chloromethylestra-1,3,5(10)-trien-3,17 beta-diol.
- In vitro biological assays to assess estrogen receptor binding and activity.
Main Results:
- Successful synthesis of Org 4333 via two distinct chemical pathways.
- Org 4333 exhibited potent estrogen agonist activity.
- The compound demonstrated irreversible binding to the estrogen receptor.
Conclusions:
- The described synthetic routes provide access to a novel estrogenic compound.
- Org 4333 represents a potent, irreversibly binding estrogen agonist with potential therapeutic applications.